본문 바로가기
KERD
논문KCI 등재

Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™)

서영준|Young Lee|임명|Jeung Hoon Lee|Ah Young Cho|Dae Hun Kim
대한피부과학회 (Korean Dermalogical Association)|2011.02|Annals of Dermatology|제23권 제1호|pp. 360-363

0

조회

0

다운로드

1

인용

0

참고문헌

키워드

Pityriasis roseaImatinib mesylate
주제분류피부과학

초록

Imatinib mesylate (Gleevec™, STI571), a selective inhibitor of BCR-ABL, c-Kit, and platelet-derived factor receptor, has been used to treat chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors. Although its use has been associated with various adverse cutaneous reactions, pityriasis rosea-like drug eruptions are rare. Here, we report a case of pityriasis rosea-like drug eruption that developed following the administration of imatinib mesylate to treat CML. (Ann Dermatol 23(S3) S360∼S363, 2011)

Abstract

Imatinib mesylate (Gleevec™, STI571), a selective inhibitor of BCR-ABL, c-Kit, and platelet-derived factor receptor, has been used to treat chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors. Although its use has been associated with various adverse cutaneous reactions, pityriasis rosea-like drug eruptions are rare. Here, we report a case of pityriasis rosea-like drug eruption that developed following the administration of imatinib mesylate to treat CML. (Ann Dermatol 23(S3) S360∼S363, 2011)

참고문헌 (19)

  1. Druker BJ, "Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia", N Engl J Med, 344, pp.1031~1037 (2001)
  2. Valeyrie L, "Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients", J Am Acad Dermatol, 48, pp.201~206 (2003)
  3. Hsiao LT, "Stevens-Johnson syndrome after treatment with STI571: a case report", Br J Haematol, 117, pp.620~622 (2002)
  4. Brouard MC, "Acute generalized exanthematous pustulosis associated with STI-571 in a patient with chronic myeloid leukemia", Dermatology, 203, pp.57~59 (2001)
  5. Schwarz M, "Imatinib-induced acute generalized exanthematous pustulosis (AGEP) in two patients with chronic myeloid leukemia", Eur J Haematol, 69, pp.254~256 (2002)
  6. Druker BJ, "Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome", N Engl J Med, 344, pp.1038~1042 (2001)
  7. 유광호, "Imatinib Mesylate에 의한 국소적 박탈피부염 양상을 보인 약진 1예", 대한피부과학회지, 46(10), pp.1435~1438 (2008), 대한피부과학회
  8. 주영현, "안와주위 부종과 박탈 피부염 소견을 보인 Imatinib Mesylate (GleevecTM)에 의한 약진 1예", 대한피부과학회지, 45(2), pp.194~196 (2007), 대한피부과학회
  9. 배유인, "Imatinib Mesylate (GleevecTM)에 의한 건선양 약진 1예", 대한피부과학회지, 47(6), pp.722~725 (2009), 대한피부과학회
  10. Woo SM, "Exacerbation of psoriasis in a chronic myelogenous leukemia patient treated with imatinib", J Dermatol, 34, pp.724~726 (2007)
  11. Konstantopoulos K, "Pityriasis rosea associated with imatinib (STI571, Gleevec)", Dermatology, 205, pp.172~173 (2002)
  12. Brazzelli V, "Pityriasis rosea-like eruption during treatment with imatinib mesylate: description of 3 cases", J Am Acad Dermatol, 53(5), pp.240~243 (2005)
  13. Lim DS, "Oral lichenoid reaction to imatinib (STI 571, Gleevec)", Dermatology, 205, pp.169~171 (2002)
  14. Basso FG, "Skin and oral lesions associated to imatinib mesylate therapy", Support Care Cancer, 17, pp.465~468 (2009)
  15. Rozieres A, "Role of T cells in nonimmediate allergic drug reactions", Curr Opin Allergy Clin Immunol, 9, pp.305~310 (2009)
  16. Brouard M, "Cutaneous reactions to STI571", N Engl J Med, 345, pp.618~619 (2001)
  17. Lammie A, "Expression of c-kit and kit ligand proteins in normal human tissues", J Histochem Cytochem, 42, pp.1417~1425 (1994)
  18. Scott LC, "Management of skin toxicity related to the use of imatinib mesylate (STI571, Glivectrade mark) for advanced stage gastrointestinal stromal tumours", Sarcoma, 9, pp.157~160 (2005)
  19. Rule SA, "Managing cutaneous reactions to imatinib therapy", Blood, 100, pp.3434~3435 (2002)

관련 논문AI추천

Imatinib Mesylate-Induced Erythema Multiforme: Recurrence after Rechallenge with 200 mg/day Imatinib권원주, 김광중, 김광호, 박은주, 이민경, 조은별대한피부과학회 · Annals of Dermatology2015 · 제27권 제5호A Case Report of Multiple Capillary Hemangioma in a Chronic Myeloid Leukemia Patient Taking Tyrosine Kinase Inhibitors박지혜, 변현정, 오세진, 이동윤, 이종은, 이종희, 임영경, 장동휘대한피부과학회 · Annals of Dermatology2021 · 제33권 제3호Oral and Cutaneous Lichenoid Eruption with Nail Changes Due to Imatinib Treatment in a Chinese Patient with Chronic Myeloid LeukemiaJian Bin Yu, Jiang An Zhang, Lei Zhao, Xiao Hong Li대한피부과학회 · Annals of Dermatology2015 · 제27권 제2호Imatinib Mesylate-Induced Acquired Dermal Melanocytosis and Acquired Bilateral Nevus of Ota-Like Macules고원선, 고주연, 노영석, 송창화, 장주왕, 정유진, 천동욱대한피부과학회 · Annals of Dermatology2021 · 제33권 제3호Dysplastic Nevus with Eruptive Melanocytic Lesions That Developed during Nilotinib Therapy for Chronic Myeloid Leukemia강진희, 박현정, 이주현, 조백기대한피부과학회 · Annals of Dermatology2015 · 제27권 제6호Exacerbation of Psoriasis after Imatinib Mesylate Treatment김준환, 박지혜, 박혜영, 심준호, 오승환, 이동윤, 전지영대한피부과학회 · Annals of Dermatology2016 · 제28권 제3호

이 간행물의 다른 논문 (64건)

Hypohidrotic Ectodermal Dysplasia Associated with Glucose-6-Phosphate Dehydrogenase DeficiencyHüseyin Gülen, Tuba Çelebİ Kayhan, Pelin Ertan, Ali Yaşar, Aylin Türel Ermertcanpp. 8-10Proximal Subungual Onychomycosis in a Patient with Classic Kaposi Sarcoma Caused by Trichophyton rubrum최종수, 이영복, 조백기, 이준영, 박현정, 이경진pp. 11-15Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory BiomarkersSeong Geun Chi, Dong Jae Park, Ho Youn Kim, 김정철, 김도원, 김문규, 이석종, 이미우, Jun Young Kim, 이원주pp. 12-18A Case of Benign Cephalic Histiocytosis김광중, 박은주, 김광호, Hee Jin Cho, Byung Chul Kim, Woo Jin Choi, Na Reu Seungpp. 16-19The Expressions of TGF-β_1 and IL-10 in Cultured Fibroblasts after ALA-IPL Photodynamic Treatment최유원, 명기범, 변지연, Ga Youn Lee, 최혜영pp. 19-22
원문 보기